These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17299168)
1. New drug and biological product approvals, 2006. Traynor K Am J Health Syst Pharm; 2007 Feb; 64(4):342, 344. PubMed ID: 17299168 [No Abstract] [Full Text] [Related]
2. New drug and biologic product approvals, 2005. Traynor K Am J Health Syst Pharm; 2006 Feb; 63(4):304, 306. PubMed ID: 16452514 [No Abstract] [Full Text] [Related]
3. New drug and biological product approvals, 2004. Traynor K Am J Health Syst Pharm; 2005 Feb; 62(4):348, 350. PubMed ID: 15745882 [No Abstract] [Full Text] [Related]
4. New drug and biological product approvals, 2012. Traynor K Am J Health Syst Pharm; 2013 Feb; 70(3):176, 178, 180. PubMed ID: 23327975 [No Abstract] [Full Text] [Related]
5. New drug and biological product approvals, 2013. Traynor K Am J Health Syst Pharm; 2014 Feb; 71(4):270. PubMed ID: 24481148 [No Abstract] [Full Text] [Related]
6. New drug and biological product approvals, 2011. Traynor K Am J Health Syst Pharm; 2012 Feb; 69(3):180-2. PubMed ID: 22261935 [No Abstract] [Full Text] [Related]
7. New drug and biological product approvals, 2007. Traynor K Am J Health Syst Pharm; 2008 Feb; 65(3):190-2. PubMed ID: 18215996 [No Abstract] [Full Text] [Related]
8. New drug and biologic product approvals in 1989. Beary JF South Med J; 1990 Nov; 83(11):1289-94. PubMed ID: 2237558 [No Abstract] [Full Text] [Related]
9. US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019. Dhodapkar MM; Ross JS; Ramachandran R JAMA Netw Open; 2023 Jun; 6(6):e2318889. PubMed ID: 37358857 [TBL] [Abstract][Full Text] [Related]
10. Regulatory watch: FDA new drug approvals in Q2 2018. Urquhart L Nat Rev Drug Discov; 2018 Jul; 17(8):536-537. PubMed ID: 30057412 [No Abstract] [Full Text] [Related]
11. Proposed accelerated FDA approvals for special medical use. Somberg JC Am J Ther; 2012 Nov; 19(6):393-4. PubMed ID: 23154227 [No Abstract] [Full Text] [Related]
12. Decisions hint that not all biologics are created with equal ease. Hutson S Nat Med; 2010 Nov; 16(11):1171. PubMed ID: 21052053 [No Abstract] [Full Text] [Related]
13. Accelerated approvals under the microscope. Mullard A Nat Rev Drug Discov; 2021 Jun; 20(6):409-411. PubMed ID: 34012001 [No Abstract] [Full Text] [Related]
14. 2010 FDA drug approvals. Mullard A Nat Rev Drug Discov; 2011 Feb; 10(2):82-5. PubMed ID: 21283092 [No Abstract] [Full Text] [Related]
15. New drug and biological product approvals, 2010. Traynor K Am J Health Syst Pharm; 2011 Feb; 68(3):186, 188, 190. PubMed ID: 21258021 [No Abstract] [Full Text] [Related]
16. New drug and biological product approvals, 2003. Traynor K Am J Health Syst Pharm; 2004 Feb; 61(4):338, 340. PubMed ID: 15011760 [No Abstract] [Full Text] [Related]
17. Clinical and regulatory features of drugs not initially approved by the FDA. Wang B; Avorn J; Kesselheim AS Clin Pharmacol Ther; 2013 Dec; 94(6):670-7. PubMed ID: 23963252 [TBL] [Abstract][Full Text] [Related]
18. Combination products regulation at the FDA. Lauritsen KJ; Nguyen T Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151 [TBL] [Abstract][Full Text] [Related]
19. The regulation of drugs and biologics: fifty years into the future. Kuhlik BN Food Drug Law J; 2000; 55(1):21-5. PubMed ID: 12269358 [No Abstract] [Full Text] [Related]
20. The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type. Torre BG; Albericio F Molecules; 2017 Feb; 22(3):. PubMed ID: 28264468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]